| 【Company Research】AAC Tech (2018 HK) - 1H25 in-line despite GPM dip; Solid outlook intact on AI-driven upgrade cycle in 2H25E |
| 【Company Research】Xunfei Healthcare (2506 HK) - Government remains the primary driving force of medical AI applications |
| 【Company Research】Tuhu Car (9690 HK) - Market share gain on superb management |
| 【Company Research】Kuaishou (1024 HK) - 2Q25 results beat; solid AI and core businesses momentum |
| 【Company Research】iQIYI (IQ US) - 2Q25 review: core membership and advertising businesses to recover in 3Q25 |
| 【Company Research】Guoquan Food (2517 HK) - A national at-home food expert to innovate at all fronts |
| 【Company Research】Kelun-Biotech (6990 HK) - Expect more important data release at ESMO 2025 |
| 【Company Research】Ke Holdings (BEKE US) - 2Q25 preview: expecting upbeat results |
| 【Company Research】WuXi Biologics (2269 HK) - Pre-IND and late-stage demand rebounded |
| 【Company Research】Baidu (BIDU US) - Ads business still takes time to recover while Robotaxi and cloud are ramping up nicely |
公司地址：香港中环花园道三号冠君大厦45-46楼
电话：（852）3900-0888 传真：（852）3761-8788
招银国际版权所有 Copyright © 2019-2026 CMB International Capital Corporation Limited. All rights reserved.
